A clinical trail of Ayurvedic therapy in management of painful menses

A randomised controlled trial to evaluate the efficacy of Hinguwadi gutika and Rajahpravartini vati in the Management of Udavarta Yonivyapad W.S.R. to Primary Dysmenorrhea.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044092

Enrollment

Registered

2022-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENTS WITH CHIEF COMPLAINT OF PAIN DURING MENSES ALONG WITH ASSOCIATED SYMPTOMS. 2. PATIENTS WHO HAVE MENSTRUAL PAIN SCORE MORE THAN GRADE I ACCORDING TO VERBAL MULTIDIMENSIONAL SCORING SYSTEM (VMSS). 3. PATIENTS WHO HAD REGULAR MENSTRAL CYCLES OF 23-35 DAYS IN THE LAST 3 MONTHS. 4. PATIENT IN AGE GROUP OF 18 TO 30 YEARS 5. PATIENTS WITH H/O USING ANALGESICS DURING MENSES. 6. PATIENT WILLING TO GIVE VOLUNTARY INFORMED CONSENT FOR THE STUDY.

Exclusion criteria

Exclusion criteria: The patient suffering from any severe systemic, or autoimmune disorders, specially those who are mentioned as Asadhya vyadhi as per clinical text of Ayurveda will be excluded. Subjects having organic pathology of uterus and adnexa like Fibroid uterus,carcinoma of endometrium, endometriosis etc. 1 having pelvic inflammatory disease or 2 chronic leucorrhoea. 3 Patients who vaccinated for covid19 with in past three month.

Design outcomes

Primary

Measure	Time frame
1. NRS â?? Scale: Numeric Rating Scale for DysmenorrhoeaTimepoint: 60 DAYS	—

Secondary

Measure	Time frame
1. VMSS scale: Verbal Multidimensional Scoring SystemTimepoint: 60 DAYS	—

Countries

India

Contacts

Public ContactPROF DR K BHARATHI

NATIONAL INSTITUTE OF AYURVEDA

baruhunt@gmail.com9492047131

Outcome results